Jul. 23 at 4:16 PM
$VRCA Verrica Pharmaceuticals announced today, July 23, 2025, that it will implement a 1-for-10 reverse stock split of its common stock.
Here are the key details:
* The reverse stock split was authorized by stockholders at the company's annual meeting on June 5, 2025.
* It becomes effective on July 24, 2025, at 5:00 p.m. ET.
* Trading will begin on a split-adjusted basis on Nasdaq on July 25, 2025, under a new CUSIP.
* Every 10 shares of Verrica's issued and outstanding common stock will automatically convert into one share, with no change to the par value per share.
* The number of outstanding shares will be reduced from approximately 92.5 million to 9.25 million.
* Fractional shares will be cashed out.
* All outstanding options and warrants, as well as shares reserved under incentive plans, will be proportionally adjusted in both share count and exercise price.
Fewer shares, more movement when positive news!
